Study reveals new insight into susceptibility to pneumonia

May 3, 2017 by David Stacey
Study reveals new insight into susceptibility to pneumonia
Credit: University of Western Australia

A new research study of immune responses to pneumococcal vaccines, commonly given to people with compromised immune systems, young children and people over 65, has identified a type of immune cell which is important in generating antibodies that prevent people from developing pneumococcal pneumonia.

In the study conducted by researchers at The University of Western Australia, people with (HIV) infection, including those successfully treated with antiretroviral therapy, and people not infected by HIV were given a pneumococcal vaccine and various immune cells and their function examined in blood before and after vaccination.

The researchers found in those without HIV infection, production of antibodies was strongly associated with a type of immune cell, called T-follicular helper cells, which are critical for generating .

In contrast, people with HIV infection produced far fewer of these cells, which was related to lower antibody responses and, importantly, these abnormalities persisted in people with treated HIV infection.

The study, published today in PLOS ONE was carried out by Dr Laila Abudulai under the supervision of Dr Sonia Fernandez and Professor Martyn French from UWA's Faculty of Health and Medical Sciences.

Dr Abudulai said that it was the first time that T-follicular helper cells had been shown to be important in the production of antibodies to pneumococcal vaccines.

"Our findings may lead to the development of new ways to assess the effectiveness of such vaccines," she said.

Professor French said that the discoveries provided new information about why people with HIV infection were much more susceptible to pneumococcal pneumonia than those without HIV infection.

"Pneumococcal vaccines are very effective in preventing pneumonia but are less effective in people with compromised immune systems, particularly HIV-infected people," he said.

"The findings presented in this paper shed important light on the mechanisms of antibody production after pneumococcal vaccination and how this is adversely affected by HIV infection."

Identification of blood immune cells that could be used as a biomarker to assess the efficacy of will be beneficial to not only HIV-infected people but also other with an increased susceptibility to pneumococcal pneumonia.

Explore further: Super-vaccine to guard against all strains of pneumococcal disease

More information: Laila N. Abudulai et al. Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection, PLOS ONE (2017). DOI: 10.1371/journal.pone.0176641

Related Stories

Super-vaccine to guard against all strains of pneumococcal disease

August 17, 2016
A new super-vaccine with the ability to eliminate all 90 known strains of the world's most deadly bacterial disease is being developed.

Researchers find key mechanism to control antibody production

April 28, 2017
A research team from iMM Lisboa led by Luís Graça has found a cellular mechanism that underlies the development of autoimmune diseases.

Newly identified antibodies may improve pneumonia vaccine design

September 22, 2011
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a novel type of antibody works against pneumococcal bacteria. The findings, which could improve vaccines against pneumonia, appear ...

Seniors need two pneumonia vaccines, CDC advisory panel says

February 3, 2015
(HealthDay)—Adults 65 and older need two vaccines to better protect them from bacterial infection in the blood (called sepsis), meningitis and pneumonia, according to a revised vaccination schedule from the 2015 Advisory ...

Team uses Google analytical tool to gauge vaccine effectiveness

February 1, 2017
Using a statistical method initially developed by Google, a Yale School of Public Health-led research team has devised a novel way to better analyze the impact of vaccines. The research was published in the Proceedings of ...

RSV infection may be associated with higher risk for bacterial pneumonia

January 6, 2015
Two common and sometimes dangerous respiratory diseases, a viral one caused by respiratory syncytial virus (RSV), and a bacterial one caused by Streptococcus pneumoniae may be linked, suggests a study published in this week's ...

Recommended for you

Study opens new avenue in quest to develop tuberculosis vaccine

November 24, 2017
A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world's deadliest infectious disease.

Discovery of potent parasite protein may lead to new therapeutic options for inflammatory bowel conditions

November 24, 2017
A single protein from a worm parasite may one day offer new therapeutic options for treating inflammatory bowel diseases like Crohn's or Ulcerative Colitis, that avoid the potentially serious side effects of current immunosuppressant ...

Druglike molecules produced by gut bacteria can affect gut, immune health

November 23, 2017
Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.

Four simple tests could help GPs spot pneumonia and reduce unnecessary antibiotics

November 23, 2017
Testing for fever, high pulse rate, crackly breath sounds, and low oxygen levels could be key to helping GPs distinguish pneumonia from less serious infections, according to a large study published in the European Respiratory ...

New approach to tracking how deadly 'superbugs' travel could slow their spread

November 22, 2017
Killer bacteria - ones that have out-evolved our best antibiotics—may not go away anytime soon. But a new approach to tracking their spread could eventually give us a fighting chance to keep their death toll down.

Research points to diagnostic test for top cause of liver transplant in kids

November 22, 2017
Biliary atresia is the most common cause of liver transplants for children in the United States. Now researchers report in Science Translational Medicine finding a strong biomarker candidate that could be used for earlier ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.